Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
6
×
astrazeneca
6
×
biotech
boston blog main
boston top stories
6
×
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
6
×
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
6
×
texas top stories
wisconsin blog main
wisconsin top stories
pfizer
bristol-myers squibb
cancer
eli lilly
amgen
celgene
clinical trials
fda
merck
microbiome
novartis
What
bio
roundup
drug
biotech
conference
fda
news
opioid
prices
seven
week
abbvie’s
acquisitions
alzheimer’s
annual
approved
assessed
attention
august
away
barbecuing
biggest
bringing
build
busy
buy
camping
cardiologist
center
ceo
ceos
check
cholesterol
communities
companies
company’s
daniel
day
days
dc
Language
unset
Current search:
astrazeneca
×
abbvie
×
" texas blog main "
×
" boston top stories "
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More